JPRN-UMIN000027808Recruiting未知
Effect of Direct Oral Anticoagulant (DOAC) in Adult Congenital Heart Disease Patients - ACHD-DOAC
niversity of Tsukuba0 sites600 target enrollmentStarted: June 19, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 600
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Age less than 20 years old 2) Incapable of obtaining participant consent 3) Judged to be medically ineligible by the attending physician
Investigators
Similar Trials
Recruiting
Not Applicable
Effects of direct oral anticoagulants (DOAC) on surgical procedures in oral and maxillofacial surgeryD68.3T81.0K08.88D48.5C44.3Haemorrhagic disorder due to circulating anticoagulantsHaemorrhage and haematoma complicating a procedure, not elsewhere classifiedSkinSkin of other and unspecified parts of faceDRKS00027934niklinik FreiburgKlinik für Mund-, Kiefer- und Gesichtschirurgie1,400
Recruiting
Phase 3
A randomized controlled, multicenter trial investigating management of Direct Oral anticoagulant (DOACs) for colorectal polypectomyColorectal polypJPRN-UMIN000039418Osaka International Cancer Institute400
Recruiting
Not Applicable
Comparison between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Interventio10011082Chronic Coronary SyndromeCoronary Artery DiseaseNL-OMON51007Zuyderland Medisch Centrum1,270
Recruiting
Not Applicable
The safety and efficacy of direct oral anticoagulants in patients with atrial fibrillation (AF)atrial fibrillationJPRN-UMIN000030673Tokyo Medical and Dental University1,000
Recruiting
Phase 4
Pharmacologic profile of direct oral anticoagulants in patients receiving Rituximab-CHOP chemotherapyewly diagnosed non-Hodgkin lymphoma,diffuse large B-cell lymphoma subtype,and who are planned to be treat with R-CHOP chemotherapy regimenTCTR20200824001Faculty of medicine Chiang Mai university26